Evidence (5043 claims)
Adoption
5831 claims
Productivity
5043 claims
Governance
4561 claims
Human-AI Collaboration
3605 claims
Labor Markets
2749 claims
Innovation
2697 claims
Org Design
2653 claims
Skills & Training
2112 claims
Inequality
1429 claims
Evidence Matrix
Claim counts by outcome category and direction of finding.
| Outcome | Positive | Negative | Mixed | Null | Total |
|---|---|---|---|---|---|
| Other | 440 | 117 | 68 | 507 | 1148 |
| Governance & Regulation | 458 | 216 | 125 | 67 | 883 |
| Research Productivity | 270 | 101 | 34 | 303 | 713 |
| Organizational Efficiency | 441 | 106 | 76 | 43 | 670 |
| Technology Adoption Rate | 347 | 130 | 76 | 45 | 603 |
| Firm Productivity | 324 | 39 | 73 | 13 | 454 |
| Output Quality | 272 | 75 | 27 | 30 | 404 |
| AI Safety & Ethics | 122 | 188 | 46 | 27 | 385 |
| Market Structure | 119 | 134 | 86 | 14 | 358 |
| Decision Quality | 182 | 79 | 41 | 20 | 326 |
| Fiscal & Macroeconomic | 95 | 58 | 34 | 22 | 216 |
| Employment Level | 78 | 37 | 80 | 9 | 206 |
| Skill Acquisition | 104 | 37 | 41 | 9 | 191 |
| Innovation Output | 124 | 12 | 26 | 13 | 176 |
| Firm Revenue | 101 | 38 | 24 | — | 163 |
| Consumer Welfare | 77 | 38 | 37 | 7 | 159 |
| Task Allocation | 93 | 17 | 36 | 8 | 156 |
| Inequality Measures | 29 | 81 | 33 | 6 | 149 |
| Regulatory Compliance | 54 | 61 | 13 | 3 | 131 |
| Task Completion Time | 92 | 8 | 4 | 3 | 107 |
| Error Rate | 45 | 53 | 6 | — | 104 |
| Worker Satisfaction | 48 | 36 | 12 | 8 | 104 |
| Training Effectiveness | 60 | 13 | 12 | 16 | 102 |
| Wages & Compensation | 56 | 16 | 20 | 5 | 97 |
| Team Performance | 50 | 13 | 15 | 8 | 87 |
| Automation Exposure | 28 | 29 | 12 | 7 | 79 |
| Job Displacement | 7 | 45 | 13 | — | 65 |
| Hiring & Recruitment | 42 | 4 | 7 | 3 | 56 |
| Developer Productivity | 38 | 4 | 4 | 3 | 49 |
| Social Protection | 22 | 12 | 7 | 2 | 43 |
| Creative Output | 17 | 8 | 6 | 1 | 32 |
| Skill Obsolescence | 3 | 26 | 2 | — | 31 |
| Labor Share of Income | 12 | 7 | 10 | — | 29 |
| Worker Turnover | 10 | 12 | — | 3 | 25 |
Productivity
Remove filter
Automation of routine administrative tasks may reduce demand for certain clerical roles while increasing demand for oversight, auditing, and legal-technical expertise, altering public-sector labor composition and retraining needs.
Qualitative labor-market reasoning based on task-based automation literature and the administrative context; no field labor-data or sample provided.
Current LLMs produce deep, reliable reasoning mainly in domains with rigorous, pre-existing abstractions (mathematics, programming) and underperform in domains that lack such formal abstractions.
Performance comparisons and observed patterns referenced qualitatively (e.g., better behavior on math and code tasks) drawn from existing literature and practitioner reports; the paper does not present new controlled benchmark experiments.
AI feedback may either augment teacher productivity (complementarity) or substitute for routine teacher feedback tasks (substitution), with unclear net labor impacts.
Workshop deliberations among 50 scholars highlighting competing theoretical scenarios; no causal labor-market evidence provided.
The approach shifts some resource demand from GPU clusters to CPU, memory, and storage I/O, meaning local SSD and CPU provisioning can become the new bottleneck.
Authors note the system relies on multi-tier I/O and CPU-side updates to enable single-GPU fine-tuning; the summary highlights this resource-shift as a risk/consideration. No quantitative cost or workload-specific tradeoff analysis is provided in the summary.
Human experts will likely shift roles from sole decision-makers to adjudicators, challengers, and validators of AI-generated arguments, changing required skills toward critical evaluation and dialectical oversight.
Conceptual labor-market projection; no empirical labor studies or surveys presented.
Productivity gains from partial automation may be offset by negative externalities (incorrect legal outcomes, appeals, reputational damage) that impose social and private costs not captured by narrow productivity measures.
Theoretical economic analysis and illustrative case vignettes describing error propagation; no empirical quantification of externalities.
Market demand will likely split between providers offering generative convenience with liability exposure and providers offering certified/verified, explainable tools at a premium, creating a two-tier market.
Market-structure analysis and illustrative projections; no empirical market data or sample size.
Reported monetary supervision cost was low (~$200) for this project, but the paper cautions that general equilibrium effects and scaling may change costs as demand for supervisors rises.
Paper provides reported supervision cost (≈$200) for the single project and includes a caveat about external validity and scaling; cost is self-reported and contextualized by authors.
Because these agents will be embedded in safety‑critical infrastructure, economic and technical outcomes will depend heavily on system architecture choices.
Systems‑engineering and policy reasoning drawing on analogies to Internet/IoT evolution and domain examples (disaster response, healthcare, industrial automation, mobility); conceptual argumentation rather than empirical measurement.
The study documents a 'silent empathy' effect: people often feel empathic concern but fail to express it in ways that align with normative empathic communication; targeted feedback helps close that expression gap.
Analysis showing mismatch between internal empathic concern (implied by context/self-report/ratings) and the presence of idiomatic empathic moves in participants' messages; targeted personalized feedback increased use of normative empathic expressions.
Liability regimes and penalties should account for limits of enforced compliance and false positives/negatives from probabilistic policy evaluations.
Normative/economic discussion in the paper highlighting probabilistic outputs of the Policy function and calibration challenges; no empirical validation.
Firms will trade off compliance strictness against service quality (task completion rates), creating an economic tradeoff that shapes market offerings (e.g., safer-but-slower vs. faster-but-riskier agents).
Economic reasoning and conceptual models in the paper; suggested objective balancing task completion and legal/reputational costs; no empirical market data.
For models/dynamics with negative LLE (contracting behavior), investment in parallel Newton tooling is likely to pay off; for expanding/chaotic dynamics (positive LLE), alternative architectural or modeling changes may be more cost-effective.
Application of the LLE convergence criterion derived in the thesis combined with empirical demonstrations on representative tasks indicating correlation between LLE sign and parallel solver performance; economic recommendation is interpretive.
The economic value of deploying DeePC-based controllers depends critically on representativeness of training data and the costs of online adaptation and safety verification.
Authors' deployment-risk analysis and discussion of trade-offs (qualitative), grounded in methodological requirements of DeePC (need for representative, persistently exciting data and safeguards).
System-level improvements from the controller do not imply uniform spatial/temporal benefits—distributional effects may favor certain routes or neighborhoods.
Authors' discussion and caution about distributional effects and equity; possibly supported by spatial analyses in simulation (qualitative discussion in paper).
Fine-tuning TSFMs on the high-frequency 5G data provides limited recovery; many configurations still perform poorly after fine-tuning.
Paper reports experiments including fine-tuning regimes where TSFMs were fine-tuned on the new dataset; results indicate limited improvement in many configurations. Specific fine-tuning procedures, datasets sizes, and quantitative results are not provided in the summary.
Reducing payrolls raises short-term firm profitability but reduces aggregate household income and consumption.
Macroeconomic accounting and labor-demand theory combined with historical examples of payroll reductions; argument is theoretical/conceptual rather than estimated with new aggregate time-series regression evidence.
Reviving model-based central planning tools (ISB+NDMS) risks political-economy problems and requires evaluation of efficiency and flexibility compared to market coordination.
Analytic discussion and normative argument in the paper; no empirical comparative study provided.
Russia's digitalization and adoption of AI/Big Data are reshaping the country's socio-economic infrastructure in multifaceted and systemic ways.
Qualitative analysis of national strategies and policy documents plus the author's expert assessments; no sample size or statistical testing reported.
Improved matches and clearer skill signals can raise short-term wages for matched youth, while longer-term wage dynamics will depend on supply responses and bargaining power shifts.
Pilot reports higher reported short-term wages; longer-term effects are discussed as conditional and not measured in the pilot.
Overall, economic benefits from AI in radiology are plausible but conditional on human-AI interaction design, governance, workforce effects, and payment structures; net value is not determined by algorithmic accuracy alone.
Synthesis of the heterogeneous literature (laboratory, reader, observational, qualitative) and conceptual economic analysis highlighting dependencies beyond algorithmic performance.
The net effect of AI on clinician burnout is ambiguous: tools can remove tedious tasks but may introduce new cognitive, administrative, and liability stresses.
Mixed qualitative and small-scale observational studies with variable findings on burnout-related measures after AI introduction.
Changes in workload composition can reduce routine burdens but may shift cognitive load to follow-up decisions and managing AI outputs.
Observational and qualitative studies of deployed systems reporting redistribution of tasks and clinician-reported changes in cognitive demands.
Economic outcomes depend on complementarity versus substitution: AI that augments radiologists can raise output per worker; AI that substitutes tasks may reduce demand for certain diagnostic activities.
Theoretical economic frameworks and case studies of task reallocation in early deployments; empirical workforce-impact studies limited.
Automation bias can increase undue reliance on AI, while algorithmic aversion can drive underuse of helpful tools.
Cognitive and behavioral studies and reader simulations demonstrating both increased acceptance/overtrust in automated outputs in some settings and rejection/discounting of AI advice in others.
Real clinical value depends critically on how AI tools interact with radiologists in practice (integration design and human-AI interaction).
Conceptual models and synthesis of reader studies, simulation/interaction studies, usability and qualitative deployment evaluations that compare standalone algorithm performance versus clinician+AI workflows.
Practical takeaway: effectiveness of human–AI teaming in security tasks depends heavily on human ability to formulate context-rich prompts; autonomous workflows that self-manage prompting and tool selection can be more effective.
Synthesis of empirical observations from the live CTF (41 participants) and the autonomous agent benchmark (4 agents), showing human prompting failures limiting team performance and autonomous agents with self-directed prompting achieving higher performance.
Participants’ perceptions, trust, and expectations about the AI shifted after hands-on use (qualitative observation).
Pre- vs. post-AI qualitative measures and observational analysis collected during the live CTF (self-reports/observations of trust and expectations after using the instrumented AI).
Implication for substitution: Because there was no main effect of partner type on collaboration proficiency, AI teammates may substitute for humans on short, temporary tasks without clear productivity loss—conditional on emotional and empathetic factors.
Inference by authors based on the null main effect of partner type combined with the observed role of emotion and service empathy in moderating/mediating collaboration proficiency (experimental evidence, n = 861).
Trust calibration influences project performance outcomes: organizations tend toward metric-driven evaluation of AI outputs and use AI to strategically augment human expertise, but miscalibration risks overreliance or inappropriate metric focus that can harm performance.
Based on participants' reported experiences in the 40 interviews and interpretive thematic analysis linking trust practices to observed/perceived performance consequences (shift to metric-based evaluation, strategic use, and noted risks).
Trust calibration shapes collaboration patterns, including delegation of oversight to systems or specialists, changes in communication networks (who talks to whom), and erosion of informal ad hoc communications used previously for tacit coordination.
Observed in interview narratives (40 interviews) and thematic coding showing repeated reports of shifted oversight roles, altered communication pathways, and reduced informal coordination after AI integration.
Trust calibration is produced and maintained through ongoing boundary work between humans and machines (i.e., teams continuously negotiate which inputs/responsibilities are treated as human versus machine).
Derived from participants' accounts in the 40 interviews and thematic analysis documenting repeated examples of role negotiation and boundary-setting between people and AI systems during project routines.
Trust in AI within project-based work is situational and socially distributed across team members, rather than a stable individual attitude.
The claim is based on thematic qualitative analysis of 40 semi-structured interviews with project professionals across multiple industries in the UK. Interview data showed variation in how different team members described their trust in systems depending on role, task, and context.
Explicit governance reduces negative externalities (bias, privacy breaches, loss of trust) but entails compliance costs that should be factored into adoption and diffusion models.
Conceptual claim synthesizing trade‑off arguments from governance and risk literatures and practitioner examples; not measured empirically in the paper.
Embedding AI into workflows may change firm boundaries (e.g., outsourcing models vs. in‑house systems) and make investments in internal auditability and explainability strategic assets.
Theoretical implication drawn from synthesis of organizational boundary theory and practitioner trends; suggested rather than empirically demonstrated within the paper.
AI is likely to continue shifting the frontier of early discovery and increase the throughput and quality of hypotheses, but persistent biological uncertainty and the cost of clinical validation mean AI will complement—not fully replace—traditional R&D for the foreseeable future.
Synthesis of technological trends, application successes and limitations, translational risk, and economic reasoning presented throughout the paper.
Proprietary data, precompetitive consortia, and platform consolidation can create barriers to entry; public-data initiatives could alter competitive dynamics.
Market-structure analysis and discussion of data-access models in the paper, with examples of consortia and proprietary platform effects.
Expect strong returns-to-scale and winner-take-most dynamics: large incumbents and well-funded startups with proprietary data/compute may dominate the field.
Economic reasoning and observations in the paper about data/compute concentration, platform effects, and market outcomes.
Realizing economic gains at scale from AI in drug R&D is constrained by data quality and access, high implementation and integration costs, regulatory uncertainty, and ethical/legal concerns; these constraints will shape how gains are distributed across firms, countries, and patients.
Aggregate conclusion of the narrative review synthesizing documented benefits and recurring constraints from published studies, case reports, industry/regulatory analyses; qualitative synthesis without quantitative projection of distributional outcomes.
Adoption of AI in pharma will increase demand for computational biologists, ML engineers, and data scientists and may displace or redefine some traditional bench roles.
Labor-market trend reports and organizational case studies included in the review noting hiring patterns and role changes; qualitative synthesis rather than comprehensive labor-market study.
AI could lower discovery costs and permit more entrants in niche/specialty therapy discovery, but clinical development costs remain a major barrier to entry.
Synthesis of reported reductions in early-stage discovery costs and persistent high clinical trial costs from studies and industry reports; heterogeneous evidence across therapeutic areas.
Upfront capital and proprietary data requirements may advantage large incumbents or well-funded startups and could increase market concentration unless data-sharing or open platforms emerge.
Market-structure analysis and industry examples in the narrative review; inference based on observed data-asset advantages and investment needs across firms.
AI shifts the cost structure of drug R&D toward higher fixed costs (data infrastructure, compute, ML talent) and potentially lower marginal costs for candidate generation and some preclinical activities.
Economic synthesis and industry reports in the review describing capital-intensive investments and reduced per-unit costs in algorithmic candidate generation; largely conceptual and based on case examples.
Early-stage unit costs and time-per-hit can fall with AI, but late-stage clinical trial costs driven by biology remain the primary bottleneck to overall R&D productivity gains.
Qualitative assessment of stage-specific effects based on industry observations and conceptual decomposition of R&D stages; no new cost accounting or econometric estimates provided.
AI can improve specific stages of drug discovery but cannot eliminate fundamental biological uncertainty.
Conceptual and thematic analysis across technological capability and R&D integration levels; supported by illustrative examples showing limits of prediction in complex biology.
Two opposing market forces will act: (a) democratization lowering entry barriers for startups, and (b) concentration where firms with premium proprietary data and integrated AI capture outsized returns.
Conceptual economic analysis and illustrative industry observations; no empirical market-structure measurement presented.
AI (including machine learning, generative AI, and NLP) is reshaping biomedical research and pharmaceutical R&D by creating distinct adoption archetypes within large pharmaceutical companies.
Editorial / conceptual synthesis using qualitative analysis and archetype classification based on cross-industry observations and illustrative examples; no systematic measurement or sample size reported.
Cross-DAO cooperation could reduce duplication and accelerate global public-good R&D (e.g., neglected diseases) but raises jurisdictional, regulatory arbitrage, and equity concerns.
Theoretical discussion and scenario analysis; no cross-DAO empirical case with measured outcomes is provided.
Techniques to mitigate data scarcity—transfer learning, data augmentation, physics-informed priors, active learning, and leveraging multimodal data—provide partial improvements but do not fully resolve generalization limits.
Review of methodological papers and empirical studies applying these techniques; synthesis indicates improvements in certain contexts but ongoing limitations documented across sources.
AI adoption shifts inventor composition within firms.
Analyses of inventor-level or inventor-aggregate characteristics before and after AI adoption showing changes in composition, using the staggered diff-in-diff approach.